Comprehensive historical analysis of global market for Post-Traumatic Stress Disorder (PTSD) has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Post-Traumatic Stress Disorder (PTSD) market.

The Global post-traumatic stress disorder (PTSD) market size was worth around USD 13.75 billion in 2024 and is predicted to grow to around USD 21.97 billion by 2035 with a compound annual growth rate (CAGR) of 4.35% from 2025 to 2035. 

The report includes growth prospects in the global Post-Traumatic Stress Disorder (PTSD) market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of Post-Traumatic Stress Disorder (PTSD) including:

• AstraZeneca Plc
• Aurobindo Pharma Limited
• Bionomics
• Camber Pharmaceuticals, Inc.
• Eli Lilly and Company
• GSK plc
• H. Lundbeck A/S
• Jazz Pharmaceuticals plc
• Johnson & Johnson Services, Inc.
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novartis AG
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• Others  

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/4303

Market split by Segement, can be divided into:

By Drug Class

• Antidepressants
• Antipsychotics
• Anti-anxiety
• Others

By Age Group

• Adult
• Geriatrics
• Pediatrics

Market segment by Region/Country including:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Check discount for this report: https://www.sphericalinsights.com/request-discount/4303

In January 2026, the Israel Defence Forces (IDF) announced a “medical revolution,” unveiling AI-assisted PTSD treatment and drone-based whole blood delivery systems designed to save lives and modernise battlefield medicine. The IDF Medical Corps has been involved in a full-fledged revolution during and after the utilisation of whole blood, artificial intelligence, and, shortly, drone delivery of whole blood, which might potentially save thousands of lives.

In October 2025, Silo Pharma announced that key milestones in its PTSD drug development program and launched a new digital assets treasury initiative. The company is preparing to file an FDA Investigational New Drug (IND) application for its lead candidate SPC-15, while also expanding its cryptocurrency holdings.

Access full Report with Table of Content @ https://www.decisionsadvisors.com/reports/post-traumatic-stress-disorder-ptsd-market

Whats covered in the report?

• 1. Overview of the Post-Traumatic Stress Disorder (PTSD) market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Post-Traumatic Stress Disorder (PTSD) market, based on segement.
• 3. Post-Traumatic Stress Disorder (PTSD) Market trends.
• 4. Post-Traumatic Stress Disorder (PTSD) Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Post-Traumatic Stress Disorder (PTSD) market.
2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Post-Traumatic Stress Disorder (PTSD) Industry.
3. Leading company profiles reveal details of key Post-Traumatic Stress Disorder (PTSD) market players emerging five operations and financial performance.
4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Post-Traumatic Stress Disorder (PTSD) market with five year historical forecasts.
5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.
6. Extensive information on factors that will amplify the growth of the Post-Traumatic Stress Disorder (PTSD) market over the upcoming seven years
7. Accurate estimation of the global Post-Traumatic Stress Disorder (PTSD) market size
8. Exact estimations of the upcoming trends and changes observed in the consumer behavior
9. Growth of the global Post-Traumatic Stress Disorder (PTSD) market across the North & South America, EMEA, Asia Pacific, and Latin America
10. Information about Post-Traumatic Stress Disorder (PTSD) market growth potential
11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors
12. Furnishing of detailed information on the factors that will restrain the growth of the Post-Traumatic Stress Disorder (PTSD) market

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: sales@sphericalinsights.com

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter